Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
High-dose Dexamethasone for Post-embolization Syndrome in PAE “Ineffective”
08/02/2023
Copenhagen, Denmark (2 August 2023) — Petra Svarc (Rigshospitalet, Copenhagen, Denmark) presented during the scientific paper session at the European Conference on Embolotherapy (ET; 21–24 June, Valencia, Spain). She imparted...
Copenhagen, Denmark (2 August 2023) — Petra Svarc (Rigshospitalet, Copenhagen, Denmark) presented during the scientific paper session at the European Conference on Embolotherapy (ET; 21–24 June, Valencia, Spain). She imparted...
Copenhagen, Denmark (2 August...
08/02/2023
IO Learning

Advertisement

News
London Hospital’s Positive 25-year Experience Offering day-case IR Service
08/02/2023
London, UK (2 August 2023) — Authors from King’s College Hospital (London, UK) have recently published a letter in Clinical Radiology detailing their centre’s experience after 25 years of day-case interventional radiology...
London, UK (2 August 2023) — Authors from King’s College Hospital (London, UK) have recently published a letter in Clinical Radiology detailing their centre’s experience after 25 years of day-case interventional radiology...
London, UK (2 August 2023) —...
08/02/2023
IO Learning
News
Humacyte Completes Enrollment in Phase II/III Trial of Human Acellular Vessel for Vascular Trauma Repair
07/31/2023
Durham, NC (31 July 2023) — Humacyte announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA) filing for the company’s Human Acellular...
Durham, NC (31 July 2023) — Humacyte announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA) filing for the company’s Human Acellular...
Durham, NC (31 July 2023)...
07/31/2023
IO Learning
News
Health Canada Approves IceCure Medical’s ProSense Cryoablation System
07/31/2023
Canada (31 July 2023) — IceCure Medical has announced in a press release that Health Canada, the Canadian government’s regulatory agency, has approved IceCure’s ProSense system, disposable cryoprobes, and introducers as cryosurgical tools for...
Canada (31 July 2023) — IceCure Medical has announced in a press release that Health Canada, the Canadian government’s regulatory agency, has approved IceCure’s ProSense system, disposable cryoprobes, and introducers as cryosurgical tools for...
Canada (31 July 2023) — IceCure...
07/31/2023
IO Learning

Advertisement

News
Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-enhanced MRI Published in Radiology
07/27/2023
Milan, Italy (27 July 2023) — Bracco Imaging has announced the publication of the PROMISE trial in Radiology. The PROMISE study was a prospective, multinational, crossover (within-patient), double-blind comparison of the safety...
Milan, Italy (27 July 2023) — Bracco Imaging has announced the publication of the PROMISE trial in Radiology. The PROMISE study was a prospective, multinational, crossover (within-patient), double-blind comparison of the safety...
Milan, Italy (27 July 2023) —...
07/27/2023
IO Learning
News
MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-based Visualization and Navigation Platform
07/24/2023
Cleveland, OH (24 July 2023) — MediView announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be...
Cleveland, OH (24 July 2023) — MediView announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be...
Cleveland, OH (24 July 2023) —...
07/24/2023
IO Learning
News
First Patient Treated in VAPOR 2 Pivotal Study for Water Vapor Ablation of Prostate Cancer
07/21/2023
Maple Grove, MN (21 July 2023) — Francis Medical, Inc, a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, has...
Maple Grove, MN (21 July 2023) — Francis Medical, Inc, a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, has...
Maple Grove, MN (21 July 2023)...
07/21/2023
IO Learning

Advertisement

News
SIR Position Statement Outlines Appropriate use of Endovascular Management for Chronic Iliofemoral Venous Occlusions
07/20/2023
Fairfax, VA (20 July 2023) — The Society of Interventional Radiology (SIR) has published a position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic...
Fairfax, VA (20 July 2023) — The Society of Interventional Radiology (SIR) has published a position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic...
Fairfax, VA (20 July 2023) — The...
07/20/2023
IO Learning
News
Endologix Announces First Patients Treated With the Detour System
07/19/2023
Cleveland, Ohio (19 July 2023) — Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since US Food and Drug Administration (FDA)...
Cleveland, Ohio (19 July 2023) — Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since US Food and Drug Administration (FDA)...
Cleveland, Ohio (19 July 2023)...
07/19/2023
IO Learning
News
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib
07/19/2023
Melbourne, Australia (19 July 2023) — Telix today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt,...
Melbourne, Australia (19 July 2023) — Telix today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt,...
Melbourne, Australia (19 July...
07/19/2023
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
Allison Casey
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023

Julia Evangelou Strait

Julia Evangelou Strait
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use